Related Experiment Video
Updated: Mar 18, 2026

08:07
Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
2.2K
Pancreatic Neoplasms and Autophagy
1University of Wyoming College of Health Sciences, School of Pharmacy, Laramie, WY 82071, United States.
Current Drug Targets
|July 1, 2016
Summary
Pancreatic cancer remains a deadly malignancy with poor survival rates. Novel therapeutic strategies, including targeting autophagy, are crucial for improving treatment outcomes for this challenging disease.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Pancreatic cancer is a highly lethal malignancy with dismal survival rates, despite advances in other gastrointestinal cancer treatments.
- Current systemic therapies like FOLFIRINOX and nabpaclitaxel plus gemcitabine offer only modest survival benefits.
- Early systemic therapy in conjunction with surgery may improve outcomes, necessitating better patient selection biomarkers.
Purpose of the Study:
- To review the current state-of-the-art treatments for pancreatic cancer.
- To explore the potential role of autophagy in developing novel therapeutic strategies against pancreatic cancer.
Main Methods:
- Literature review of preclinical and clinical studies on pancreatic cancer treatment.
- Analysis of current therapeutic regimens and their efficacy.
- Investigation into the biological mechanisms of autophagy in pancreatic cancer.
Main Results:
- Pancreatic cancer treatment remains challenging, with limited efficacy of existing chemotherapies.
- Biomarkers are needed to identify patients who may benefit from specific systemic therapies.
- Autophagy presents a promising target for novel therapeutic interventions in pancreatic cancer.
Conclusions:
- There is an urgent need for novel therapeutic approaches to improve pancreatic cancer survival.
- Targeting autophagy may offer a promising new avenue for pancreatic cancer treatment.
- Further research into autophagy modulation is warranted for clinical application.
Related Concept Videos
Autophagic Cell Death
4.9K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Autophagy
6.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome
10.4K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Phagocytosis of Apoptotic Cells
5.5K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
5.5K
Chronic Pancreatitis I: Introduction
851
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
851

